The Solution Spray
NDC Package 82617-101-14

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

The Solution (lidocaine hydrochloride, epinephrine hydrochloride) sprays is cLEAN THE AFFECTED AREA.SENSITIVITY AND POSSIBLE ALLERGY TESTS ADVISED PRIOR TO USE. This formulation utilizes a spray delivery system. Marketed by Scalp Tech Inc, this product is identified by NDC 82617-101 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
82617-101-14
Package Description
118 mL in 1 BOTTLE, SPRAY
Product Code
82617-101
11-Digit Billing Format
82617010114
RxNorm Crosswalk
  • RxCUI: 2601579 - EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Rectal Spray
  • RxCUI: 2601579 - epinephrine hydrochloride 0.1 MG/ML / lidocaine hydrochloride 50 MG/ML Rectal Spray
  • RxCUI: 2601579 - epinephrine hydrochloride 0.01 % / lidocaine hydrochloride 5 % Rectal Spray

Clinical Specifications

Proprietary Name
The Solution
Non-Proprietary Name
Lidocaine Hydrochloride, Epinephrine Hydrochloride
Substance Name
Epinephrine Hydrochloride; Lidocaine Hydrochloride
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
CLEAN THE AFFECTED AREA.SENSITIVITY AND POSSIBLE ALLERGY TESTS ADVISED PRIOR TO USE. SPRAY SPARINGLY TO AFFECTED AREA AFTER THOROUGHLY CLEANSING. WAIT UNTIL ANESTHETIC EFFECT OCCURS. YOU MAY REAPPLY TO CONTINUE NUMBING AFFECT.APPLY TO THE AFFECTED AREA UP TO 4 TIMES DAILY.CHILDREN UNDER 12 YEARS OF AGE, CONSULT A DOCTOR.

Regulatory & Marketing

Labeler Name
Scalp Tech Inc
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-01-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82617-101-14 identifies a specific commercial package of 118 ml in 1 bottle, spray of The Solution, a human over the counter drug labeled by Scalp Tech Inc. This spray is formulated for topical use and contains epinephrine hydrochloride; lidocaine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Scalp Tech Inc on April 01, 2022. The current certification is valid through December 31, 2026.

How is this Scalp Tech Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82617010114. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82617-101-14
11-Digit CMS (5-4-2)
82617-0101-14

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.